"pancreatic adenocarcinoma" trang 1 - tải miễn phí từ tailieunhanh
Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma

Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma
11    39    1
A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis

A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis
11    60    1
Outcomes of patients with initially locally advanced pancreatic adenocarcinoma who did not benefit from resection: A prospective cohort study

Outcomes of patients with initially locally advanced pancreatic adenocarcinoma who did not benefit from resection: A prospective cohort study
9    82    0
Proposal for a definition of

Proposal for a definition of "Oligometastatic disease in pancreatic cancer"
13    64    0
Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma

Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
9    57    1
Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma

Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma
9    28    1
Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma

Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma
6    51    1
NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): From clinical trials to clinical practice

NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): From clinical trials to clinical practice
8    64    1
Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma

Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma
11    41    1
GLUT-1 as a predictor of worse prognosis in pancreatic adenocarcinoma: Immunohistochemistry study showing the correlation between expression and survival

GLUT-1 as a predictor of worse prognosis in pancreatic adenocarcinoma: Immunohistochemistry study showing the correlation between expression and survival
9    33    1
Expression of astrocyte elevated gene-1 (AEG-1) as a biomarker for aggressive pancreatic ductal adenocarcinoma

Expression of astrocyte elevated gene-1 (AEG-1) as a biomarker for aggressive pancreatic ductal adenocarcinoma
10    58    1
The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: An immunohistochemical study of tissue microarrays

The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: An immunohistochemical study of tissue microarrays
10    60    1
High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma

High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma
12    59    1
Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: Separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy

Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: Separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy
12    40    2
Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head

Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head
11    32    1
Multicenter randomized controlled trial and registry study to assess the safety and efficacy of the NanoKnife® system for the ablation of stage 3 pancreatic adenocarcinoma: Overview of study protocols

Multicenter randomized controlled trial and registry study to assess the safety and efficacy of the NanoKnife® system for the ablation of stage 3 pancreatic adenocarcinoma: Overview of study protocols
10    27    1
GLRX3, a novel cancer stem cell-related secretory biomarker of pancreatic ductal adenocarcinoma

GLRX3, a novel cancer stem cell-related secretory biomarker of pancreatic ductal adenocarcinoma
19    50    1
A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma

A neoadjuvant therapy compatible prognostic staging for resected pancreatic ductal adenocarcinoma
12    1    1
Comprehensive analysis identifies cuproptosis-related gene DLAT as a potential prognostic and immunological biomarker in pancreatic adenocarcinoma

Comprehensive analysis identifies cuproptosis-related gene DLAT as a potential prognostic and immunological biomarker in pancreatic adenocarcinoma
18    7    1
Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: A retrospective study

Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: A retrospective study
9    116    0